and Obsessive-Compulsive Personality Disorder. Cluster C personality disorders. Patients in the anxious Dependent fearful personality cluster including the Avoidant
Conditions
Interventions
See the METC protocol 5.1 (page 16-17) for more information.
Pre-treatment (B1)
In line with general guidelines and the used protocol in this study (e.g.
short-term schema therapy, experiential tec
Sponsors
GGZ Delfland (Delft)
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: (1) Principal diagnosis of a DSM-5 cluster C PD (e.g. avoidant, obsessive-compulsive and/or dependent PD), determined by a structured interview (SCID-5-PD) (2) Age between 18 and 65 years (3) Possession of a smartphone, laptop or a desktop computer (4) Written informed consent, including consent to audiotape the sessions (5) Ability to read, write and speak the Dutch language
Exclusion criteria
Exclusion criteria: (1) Non-detoxified alcohol- or drugs dependence (inclusion is possible after detoxification) (2) Full diagnosis of comorbid DSM-5 cluster A or B PD determined by a structured interview (SCID-5-P) (3) Level of education lower than preparatory secondary vocational education (4) Experience with ST in the past year (5) Following other psychological treatments during the study. Pharmacotherapy is allowed as a co-intervention if it was already started before participating in the study. It is protocol that medication (dose) will not be changed during participation in this study, except when a crisis situation requires deviation from protocol (see chapter 9 AEs, SAEs). Participation in the study will end if dosages are changed (6) High suicide risk as determined by the treating therapist (suicide taxation when suicidal ideations are present) (7) A (history of) psychotic or bipolar disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| See the METC protocol 8.1 (page 20) for more information about the measurement method, instruments and assessment moments. Overall wellbeing (ORS) To asses change in overall wellbeing after pre-treatment, treatment, 3 months treatment-FU and at 6 months measurement-FU (compared to baseline), participants will fill in the Outcome Rating Scale (ORS; Miller & Duncan, 2000; Miller, Duncan, Brown, Sparks, & Claud, 2003; Dutch manual by Crouzen, 2010). Participants will fill in this questionnaire once every two days during phase A1, twice a week during phase B1, once a week during phase B2 and A2 and once at 6 months measurement-FU, with a total of 53-64 offered measurement points. | — |
Secondary
| Measure | Time frame |
|---|---|
| See the METC protocol 8.1 (page 20-22) for more information about the measurement method, instruments and assessment moments. Severity of cluster C PD (SCID-5-PD) To asses and evaluate change in cluster C PD severity at 6 months measurement--FU (compared to before baseline), the Structured Clinical Interview for DSM-5 personality disorders (SCID-5-PD; First, Williams, Benjamin & Spitzer, 2015; Dutch translation Arntz, Kamphuis & Derks, 2017) will be administered. Behavioral Treatment Goals (BTG) To asses progress in two SMART formulated Behavioral Treatment Goals (BTG) after pre-treatment, treatment, 3 months treatment-FU and at 6 months measurement-FU (compared to baseline), participants will score these goals on a VAS from 0-100, with 0 referring to *goal not achieved at all*, and 100 *achieved a lot more than goal*. Participants will score their goals with the same frequency as the ORS and NCB, with a total of 53-64 offered measurement points. At 6 months measurement-FU, qualitative information about participants* experience with setting, tracking and evaluating goals will be gathered during a 15 minutes open-question interview. Negative Core Beliefs (NCB) To asses change in credibility of Negative Core Beliefs (NCB) after pre-treatment, treatment, 3 months treatment-FU and at 6 months measurement-FU (compared to baseline), participants will rate the credibility of their two most prominent negative core beliefs on a VAS of 0-100%, with the same frequency as the ORS and BTG, with a total of 53-64 offered measurement points. General mental distress (BSI) To asses change in general mental distress after pre-treatment, treatment, 3 months treatment-FU and at 6 months measurement-FU(compared to baseline), participants will fill in the Brief Symptom Inventory (BSI; de Beurs, 2011; translated from Derogatis, 1975). Participants will fill this in at the start/end of every phase, during an evaluation moment in phase B2 and at 6 months measur | — |
Countries
Netherlands
Outcome results
None listed